Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on August 25, 2025
Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108
GlobeNewswire
·
August 25, 2025
– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan – Segment provides further insight into the need for more effective treatment options for FSCD and how PALI-2108 may …
NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
GlobeNewswire
·
August 25, 2025
CALABASAS, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced the closing of its …
WISeKey Unveils Its Next-Generation WISeID: A Fully Decentralized Identity Platform for People and Objects
GlobeNewswire
·
August 25, 2025
WISeKey Unveils Its Next-Generation WISeID: A Fully Decentralized Identity Platform for People and Objects Geneva, Switzerland – August 25, 2025 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, …
Sagtec Global Secures AI Licensing Deal with Kinetic Seas to Accelerate Scalable Growth in F&B Tech Market
GlobeNewswire
·
August 25, 2025
KUALA LUMPUR, MALAYSIA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Sagtec Global (NASDAQ: SAGT), a leading innovator in Point-of-Sale (POS) systems, today announced a strategic licensing agreement with Kinetic Seas Incorporated (OTCQB: KSEZ). Through the agreement, …
Kinetic Seas and Sagtec Enter into Major Five-Year Agreement to Launch Private White-Labeled SKILLIKS Platform
GlobeNewswire
·
August 25, 2025
SCHAUMBURG, Ill. and KUALA LUMPUR, Malaysia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kinetic Seas Incorporated (OTCQB: KSEZ) and Sagteс Global Limited (NASDAQ: SAGT) today announced the signing of a multi-year agreement to deploy a private white-labeled version …
Global Suppositories Market to Surpass USD 2.05 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 25, 2025
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global suppositories market, valued at US$1.56 billion in 2024, stood at US$1.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.7% from 2025 to 2030, culminating in a forecasted …
VERSES® Receives Patent for Specifying Domain Models with Active Inference Agents
GlobeNewswire
·
August 25, 2025
VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, today announces that a patent was …
AITX’s RAD Launches Logistics Market Solution With ROAMEO
GlobeNewswire
·
August 25, 2025
Client Feedback from Complete RAD Security Solution Offers Significant Potential Detroit, Michigan, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), along with its wholly owned subsidiary, …
Global Veterinary Diagnostics Market Set to Reach USD 5.36 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 25, 2025
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global veterinary diagnostics market, valued at US$3.42 billion in 2024, stood at US$3.68 billion in 2025 and is projected to advance at a resilient CAGR of 7.8% from 2025 to 2030, culminating in a …
PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
GlobeNewswire
·
August 25, 2025
Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of care pembrolizumab or pembrolizumab + chemotherapy is 17.9 months* VERSATILE-003 Phase 3 trial in progress PRINCETON, N.J., Aug. 25, 2025 (GLOBE …
Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
GlobeNewswire
·
August 25, 2025
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More than 50 million people affected by acne in US each year, …
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
GlobeNewswire
·
August 25, 2025
DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage …
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals
GlobeNewswire
·
August 25, 2025
CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market
GlobeNewswire
·
August 25, 2025
Company’s pembrolizumab-based immune checkpoint inhibitor exhibited success against solid tumors in IND-enabling studies by simultaneously activating immune cells and promoting their infiltration into solid tumors Presentation at Nova Southeastern …
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
GlobeNewswire
·
August 25, 2025
DUBLIN and BRIDGEWATER, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2025, August 29th-September 1st, in Madrid, Spain, where new …
Arnatar Therapeutics Emerges from Stealth and Announces Receipt of FDA Orphan Drug and Rare Pediatric Disease Designations for ART4
GlobeNewswire
·
August 25, 2025
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, emerges from stealth today and announces that the U.S. Food and Drug Administration (FDA) has …
Smarter, Faster, and More Human: Cerence AI and Volkswagen Advance Partnership to Deliver Next-Gen In-Car Conversations
GlobeNewswire
·
August 25, 2025
BURLINGTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced the next evolution of its successful collaboration with the Volkswagen …
SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025
GlobeNewswire
·
August 25, 2025
JERSEY CITY, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Scynexis senior …
Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 25, 2025
AUSTIN, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders, such as Tuberous …
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting
GlobeNewswire
·
August 25, 2025
STOUGHTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present nine posters showcasing real-world data from its differentiated pain portfolio at PAINWeek 2025, taking place in Las Vegas, NV …